Economic aspects of the fixed combinations of lipid lowering medicines in group risks patients
Relevance. Cardio-vascular diseases (CVD) are the one of the main reasons of mortality and disability. Hypercholesterinemia is a factor of CVD progression, and thus it should be corrected. Combination of statin + ezetemib is an effective option of a medical technology for this purpose. Pharmacoecono...
Saved in:
Main Authors: | M. V. Zhuravleva (Author), M. Yu. Frolov (Author), E. A. Luchinin (Author), K. A. Kokushkin (Author), E. D. Laryushkina (Author), T. R. Kameneva (Author), E. V. Kuznetsova (Author) |
---|---|
Format: | Book |
Published: |
Izdatelstvo OKI,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation
by: M. V. Zhuravleva, et al.
Published: (2024) -
Ademetionine treatment cost analysis of patients with intrahepatic cholestasis and non-alcoholic fatty disease
by: M. V. Zhuravleva, et al.
Published: (2022) -
Economic evaluation of the fixed combination of insulin glargine and lixisenatide in Diabetes Mellitus type 2
by: S. V. Nedogoda, et al.
Published: (2020) -
ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES
by: V. S. Krysanova, et al.
Published: (2021) -
Pharmacoepidemiological Research of the Efficacy of Fixed Dose Combinations in the Treatment of Patients with Arterial Hypertension in Ambulatory Practice
by: E. V. Yakukhnaya, et al.
Published: (2019)